Abstract
In humans and other vertebrates, thyroid hormone is essential to the development and function of every tissue in the body. During adulthood, thyroid hormone is critical to mediating changes in metabolism as it is key to the regulation of resting energy expenditure, body temperature, and hepatic lipid metabolism, to name a few. The hypothalamic-pituitary-thyroid (HPT) axis functions as a negative feedback loop where thyrotropin-releasing hormone (TRH) is released from neurons in the paraventricular nucleus of the hypothalamus and stimulates the secretion of thyroid-stimulating hormone (TSH) from the pituitary. TSH signals the release of thyroid hormones, both the prohormone thyroxine (T4) and the active hormone triiodothyronine (T3) from the thyroid. Through central actions, TRH and TSH are negatively regulated by T3 at several levels including gene transcription and prohormone processing. The HPT axis is a dynamic system that responds to environment including food availability, environmental temperature, weight loss, and illness normally through central mechanisms. The following chapter will focus on the regulation of thyroid hormone, its role in body weight, and how weight loss can affect thyroid hormone levels. Currently, thyroid hormone is a poor therapeutic to treat obesity and to elevate energy expenditure because it has detrimental effects such as atrial fibrillation, osteoporosis, and muscle wasting. Researchers are focusing on thyroid hormone analogs as therapeutics for weight loss to eliminate the negative side effects. As detailed below, thyroid hormone action in peripheral tissues can be just as important to energy expenditure as the central regulation of thyroid hormone.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abel, E. D., Ahima, R. S., Boers, M. E., Elmquist, J. K., & Wondisford, F. E. (2001). Critical role for thyroid hormone receptor beta2 in the regulation of paraventricular thyrotropin-releasing hormone neurons. The Journal of Clinical Investigation, 107, 1017–1023.
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996). Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250–252.
Alland, L., Muhle, R., Hou, H., Jr., Potes, J., Chin, L., Schreiber-Agus, N., & DePinho, R. A. (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature, 387, 49–55.
Antonelli, A., Fallahi, P., Ferrari, S. M., Di Domenicantonio, A., Moreno, M., Lanni, A., & Goglia, F. (2011). 3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. Journal of Biological Regulators and Homeostatic Agents, 25, 655–660.
Astapova, I., Lee, L. J., Morales, C., Tauber, S., Bilban, M., & Hollenberg, A. N. (2008). The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo. Proceedings of the National Academy of Sciences of the United States of America, 105, 19544–19549.
Astapova, I., et al. (2011). The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis. Molecular Endocrinology (Baltimore, MD), 25, 212–224.
Barker, S. B. (1951). Mechanism of action of the thyroid hormone. Physiological Reviews, 31, 205–243.
Baxter, J. D., & Webb, P. (2009). Thyroid hormone mimetics: Potential applications in atherosclerosis, obesity and type 2 diabetes. Nature Reviews. Drug Discovery, 8, 308–320. https://doi.org/10.1038/nrd2830.
Beck-Peccoz, P., Amr, S., Menezes-Ferreira, M. M., Faglia, G., & Weintraub, B. D. (1985). Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. The New England Journal of Medicine, 312, 1085–1090. https://doi.org/10.1056/NEJM198504253121703.
Benvenga, S., Cahnmann, H. J., Rader, D., Kindt, M., Facchiano, A., & Robbins, J. (1994). Thyroid hormone binding to isolated human apolipoproteins A-II, C-I, C-II, and C-III: Homology in thyroxine binding sites. Thyroid, 4, 261–267. https://doi.org/10.1089/thy.1994.4.261.
Bjorbaek, C., & Hollenberg, A. N. (2002). Leptin and melanocortin signaling in the hypothalamus. Vitamins and Hormones, 65, 281–311.
Blake, N. G., Eckland, D. J., Foster, O. J., & Lightman, S. L. (1991). Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology, 129, 2714–2718.
Blake, N. G., Johnson, M. R., Eckland, D. J., Foster, O. J., & Lightman, S. L. (1992). Effect of food deprivation and altered thyroid status on the hypothalamic-pituitary-thyroid axis in the rat. The Journal of Endocrinology, 133, 183–188.
Bobek, S., Sechman, A., Niezgoda, J., & Jacek, T. (2002). Reverse 3,3′,5′-triiodothyronine suppresses increase in free fatty acids in chickens elicited by dexamethasone or adrenaline. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine, 49, 121–124.
Bochukova, E., et al. (2012). A mutation in the thyroid hormone receptor alpha gene. The New England Journal of Medicine, 366, 243–249. https://doi.org/10.1056/NEJMoa1110296.
Bowers, C. R., Redding, T. W., & Schally, A. V. (1965). Effect of thyrotropin releasing factor (TRF) of ovine, bovine, porcine and human origin on thyrotropin release in vitro and in vivo. Endocrinology, 77, 609–616. https://doi.org/10.1210/endo-77-4-609.
Brent, G. A. (2012). Mechanisms of thyroid hormone action. The Journal of Clinical Investigation, 122, 3035–3043. https://doi.org/10.1172/JCI60047.
Burch, H. B., & Wartofsky, L. (1993). Life-threatening thyrotoxicosis. Thyroid storm Endocrinol Metab Clin North Am, 22, 263–277.
Cable, E. E., et al. (2009). Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology, 49, 407–417. https://doi.org/10.1002/hep.22572.
Celi, F. S., et al. (2011). Metabolic effects of liothyronine therapy in hypothyroidism: A randomized, double-blind, crossover trial of liothyronine versus levothyroxine. The Journal of Clinical Endocrinology and Metabolism, 96, 3466–3474. https://doi.org/10.1210/jc.2011-1329.
Chiamolera, M. I., & Wondisford, F. E. (2009). Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology, 150, 1091–1096.
Connors, J. M., DeVito, W. J., & Hedge, G. A. (1985). Effects of food deprivation on the feedback regulation of the hypothalamic-pituitary-thyroid axis of the rat. Endocrinology, 117, 900–906.
Costa-e-Sousa, R. H., & Hollenberg, A. N. (2012). Minireview: The neural regulation of the hypothalamic-pituitary-thyroid axis. Endocrinology, 153, 4128–4135.
Cypess, A. M., et al. (2009). Identification and importance of brown adipose tissue in adult humans. The New England Journal of Medicine, 360, 1509–1517. https://doi.org/10.1056/NEJMoa0810780.
Du Bois, E. F. (1936). Basal metabolism in health and disease (3rd ed.). Philadelphia: Lea & Febiger.
Erion, M. D., et al. (2007). Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proceedings of the National Academy of Sciences of the United States of America, 104, 15490–15495. https://doi.org/10.1073/pnas.0702759104.
Farwell, A. P., Lynch, R. M., Okulicz, W. C., Comi, A. M., & Leonard, J. L. (1990). The actin cytoskeleton mediates the hormonally regulated translocation of type II iodothyronine 5′-deiodinase in astrocytes. The Journal of Biological Chemistry, 265, 18546–18553.
Fekete, C., et al. (2001). Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology, 142, 2606–2613.
Fekete, C., et al. (2000). alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. The Journal of Neuroscience, 20, 1550–1558.
Fekete, C., Sarkar, S., Rand, W. M., Harney, J. W., Emerson, C. H., Bianco, A. C., & Lechan, R. M. (2002). Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis. Endocrinology, 143, 3846–3853.
Flores-Morales, A., Gullberg, H., Fernandez, L., Stahlberg, N., Lee, N. H., Vennstrom, B., & Norstedt, G. (2002). Patterns of liver gene expression governed by TRbeta. Molecular Endocrinology (Baltimore, MD), 16, 1257–1268. https://doi.org/10.1210/mend.16.6.0846.
Forrest, D., Erway, L. C., Ng, L., Altschuler, R., & Curran, T. (1996). Thyroid hormone receptor beta is essential for development of auditory function. Nature Genetics, 13, 354–357. https://doi.org/10.1038/ng0796-354.
Forrest, D., & Vennstrom, B. (2000). Functions of thyroid hormone receptors in mice. Thyroid, 10, 41–52. https://doi.org/10.1089/thy.2000.10.41.
Friesema, E. C., Jansen, J., & Visser, T. J. (2005). Thyroid hormone transporters. Biochemical Society Transactions, 33, 228–232. https://doi.org/10.1042/BST0330228.
Friesema, E. C., Visser, W. E., & Visser, T. J. (2010). Genetics and phenomics of thyroid hormone transport by MCT8. Molecular and Cellular Endocrinology, 322, 107–113. https://doi.org/10.1016/j.mce.2010.01.016.
Geras, E. J., & Gershengorn, M. C. (1982). Evidence that TRH stimulates secretion of TSH by two calcium-mediated mechanisms. The American Journal of Physiology, 242, E109–E114.
Gereben, B., McAninch, E. A., Ribeiro, M. O., & Bianco, A. C. (2015). Scope and limitations of iodothyronine deiodinases in hypothyroidism. Nature Reviews. Endocrinology, 11, 642–652. https://doi.org/10.1038/nrendo.2015.155.
Giudetti, A. M., Leo, M., Siculella, L., & Gnoni, G. V. (2006). Hypothyroidism down-regulates mitochondrial citrate carrier activity and expression in rat liver. Biochimica et Biophysica Acta, 1761, 484–491. https://doi.org/10.1016/j.bbalip.2006.03.021.
Goldstein, J. L., DeBose-Boyd, R. A., & Brown, M. S. (2006). Protein sensors for membrane sterols. Cell, 124, 35–46. https://doi.org/10.1016/j.cell.2005.12.022.
Grant, N. (2007). The role of triiodothyronine-induced substrate cycles in the hepatic response to overnutrition: Thyroid hormone as an antioxidant. Medical Hypotheses, 68, 641–649. https://doi.org/10.1016/j.mehy.2006.07.045.
Grasselli, E., Canesi, L., Voci, A., De Matteis, R., Demori, I., Fugassa, E., & Vergani, L. (2008). Effects of 3,5-diiodo-L-thyronine administration on the liver of high fat diet-fed rats. Experimental Biology and Medicine (Maywood, N.J.), 233, 549–557. https://doi.org/10.3181/0710-RM-266.
Greer, M. A. (1951). Evidence of hypothalamic control of the pituitary release of thyrotropin. Proceedings of the Society for Experimental Biology and Medicine, 77, 603–608.
Guillemin, R., Sakiz, E., & Ward, D. N. (1965). Further purification of Tsh-releasing factor (Trf) from sheep hypothalamic tissues, with observations on the amino acid composition. Proceedings of the Society for Experimental Biology and Medicine, 118, 1132–1137.
Guillemin, R., Yamazaki, E., Gard, D. A., Jutisz, M., & Sakiz, E. (1963). In vitro secretion of thyrotropin (Tsh): Stimulation by a hypothalamic peptide (Trf). Endocrinology, 73, 564–572. https://doi.org/10.1210/endo-73-5-564.
Gullberg, H., Rudling, M., Forrest, D., Angelin, B., & Vennstrom, B. (2000). Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Molecular Endocrinology (Baltimore, MD), 14, 1739–1749. https://doi.org/10.1210/mend.14.11.0548.
Gullberg, H., Rudling, M., Salto, C., Forrest, D., Angelin, B., & Vennstrom, B. (2002). Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Molecular Endocrinology (Baltimore, MD), 16, 1767–1777. https://doi.org/10.1210/me.2002-0009.
Haber, R. S., Ismail-Beigi, F., & Loeb, J. N. (1988). Time course of na,k transport and other metabolic responses to thyroid hormone in clone 9 cells. Endocrinology, 123, 238–247. https://doi.org/10.1210/endo-123-1-238.
Halachmi, S., Marden, E., Martin, G., MacKay, H., Abbondanza, C., & Brown, M. (1994). Estrogen receptor-associated proteins: Possible mediators of hormone-induced transcription. Science (New York, NY), 264, 1455–1458.
Heijlen, M., et al. (2014). Knockdown of type 3 iodothyronine deiodinase severely perturbs both embryonic and early larval development in zebrafish. Endocrinology, 155, 1547–1559. https://doi.org/10.1210/en.2013-1660.
Heinzel, T., et al. (1997). A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature, 387, 43–48.
Hu, X., & Lazar, M. A. (1999). The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature, 402, 93–96. https://doi.org/10.1038/47069.
Jackson-Hayes, L., et al. (2003). A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Ialpha gene mediates the liver-specific induction by thyroid hormone. The Journal of Biological Chemistry, 278, 7964–7972. https://doi.org/10.1074/jbc.M211062200.
Jepsen, K., Gleiberman, A. S., Shi, C., Simon, D. I., & Rosenfeld, M. G. (2008). Cooperative regulation in development by SMRT and FOXP1. Genes & Development, 22, 740–745. https://doi.org/10.1101/gad.1637108.
Jepsen, K., et al. (2000). Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell, 102, 753–763.
Kaneshige, M., et al. (2001). A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice. Proceedings of the National Academy of Sciences of the United States of America, 98, 15095–15100. https://doi.org/10.1073/pnas.261565798.
Katzeff, H. L., Yang, M. U., Presta, E., Leibel, R. L., Hirsch, J., & Van Itallie, T. B. (1990). Calorie restriction and iopanoic acid effects on thyroid hormone metabolism. The American Journal of Clinical Nutrition, 52, 263–266.
Klein, I., & Danzi, S. (2007). Thyroid disease and the heart. Circulation, 116, 1725–1735. https://doi.org/10.1161/CIRCULATIONAHA.106.678326.
Klieverik, L. P., et al. (2009). Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. Proceedings of the National Academy of Sciences of the United States of America, 106, 5966–5971. https://doi.org/10.1073/pnas.0805355106.
Klieverik, L. P., Sauerwein, H. P., Ackermans, M. T., Boelen, A., Kalsbeek, A., & Fliers, E. (2008). Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats. American Journal of Physiology, 294, E513–E520. https://doi.org/10.1152/ajpendo.00659.2007.
Kopp, P. (2005). Thyroid hormone synthesis: Thyroid iodine metabolism. In L. U. R. Braverman (Ed.), Wegner and Ingbar's the thyroid: A fundamental and clinical text (pp. 52–76). USA: Lippincott Williams & Wilkins.
Lanni, A., et al. (2005). 3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. The FASEB Journal, 19, 1552–1554. https://doi.org/10.1096/fj.05-3977fje.
Lazar, M. A. (1993). Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocrine Reviews, 14, 184–193.
Le, T. N., Celi, F. S., & Wickham, E. P., 3rd. (2016). Thyrotropin levels are associated with cardiometabolic risk factors in euthyroid adolescents. Thyroid, 26, 1441–1449. https://doi.org/10.1089/thy.2016.0055.
Lechan, R. M., & Hollenberg, A. N. (2003). Thyrotropin-releasing hormone (TRH). In H. L. Henry & A. W. Norman (Eds.), Encyclopedia of hormones (pp. 510–524). New York: Elsevier Science.
Lechan, R. M., Wu, P., Jackson, I. M., Wolf, H., Cooperman, S., Mandel, G., & Goodman, R. H. (1986). Thyrotropin-releasing hormone precursor: Characterization in rat brain. Science (New York, NY), 231, 159–161.
Legradi, G., Emerson, C. H., Ahima, R. S., Flier, J. S., & Lechan, R. M. (1997). Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology, 138, 2569–2576.
Legradi, G., & Lechan, R. M. (1998). The arcuate nucleus is the major source for neuropeptide Y-innervation of thyrotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Endocrinology, 139, 3262–3270.
Lombardi, A., Lanni, A., Moreno, M., Brand, M. D., & Goglia, F. (1998). Effect of 3,5-di-iodo-L-thyronine on the mitochondrial energy-transduction apparatus. The Biochemical Journal, 330(Pt 1), 521–526.
Lonard, D. M., & O'Malley, B. W. (2007). Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Molecular Cell, 27, 691–700. https://doi.org/10.1016/j.molcel.2007.08.012.
Lopez, D., Abisambra Socarras, J. F., Bedi, M., & Ness, G. C. (2007). Activation of the hepatic LDL receptor promoter by thyroid hormone. Biochimica et Biophysica Acta, 1771, 1216–1225. https://doi.org/10.1016/j.bbalip.2007.05.001.
Maglich, J. M., Watson, J., McMillen, P. J., Goodwin, B., Willson, T. M., & Moore, J. T. (2004). The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. The Journal of Biological Chemistry, 279, 19832–19838.
Mangus-Levy, A. (1895). Uber den respiratorischen Gaswechsel unter dem Einfluss der Thyroiden sowie unter verschiedenen physiologischen. Zustanden Berlin klinische Wochenschrift, 32, 650–652.
Martin, J. B., Boshans, R., & Reichlin, S. (1970). Feedback regulation of TSH secretion in rats with hypothalamic lesions. Endocrinology, 87, 1032–1040. https://doi.org/10.1210/endo-87-5-1032.
Menezes-Ferreira, M. M., Petrick, P. A., & Weintraub, B. D. (1986). Regulation of thyrotropin (TSH) bioactivity by TSH-releasing hormone and thyroid hormone. Endocrinology, 118, 2125–2130. https://doi.org/10.1210/endo-118-5-2125.
Mittag, J., et al. (2013). Thyroid hormone is required for hypothalamic neurons regulating cardiovascular functions. The Journal of Clinical Investigation, 123, 509–516. https://doi.org/10.1172/JCI65252.
Mol, J. A., & Visser, T. J. (1985). Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology, 117, 8–12.
Mollica, M. P., et al. (2009). 3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. Journal of Hepatology, 51, 363–370. https://doi.org/10.1016/j.jhep.2009.03.023.
Moreno, M., Lanni, A., Lombardi, A., & Goglia, F. (1997). How the thyroid controls metabolism in the rat: Different roles for triiodothyronine and diiodothyronines. The Journal of Physiology, 505(Pt 2), 529–538.
Moreno, M., et al. (2011). 3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. The FASEB Journal, 25, 3312–3324. https://doi.org/10.1096/fj.11-181982.
Mullur, R., Liu, Y. Y., & Brent, G. A. (2014). Thyroid hormone regulation of metabolism. Physiological Reviews, 94, 355–382. https://doi.org/10.1152/physrev.00030.2013.
Nagy, L., et al. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell, 89, 373–380.
Nagy, L., et al. (1999). Mechanism of corepressor binding and release from nuclear hormone receptors. Genes & Development, 13, 3209–3216.
Ng, L., Cordas, E., Wu, X., Vella, K. R., Hollenberg, A. N., & Forrest, D. (2015). Age-related hearing loss and degeneration of Cochlear hair cells in mice lacking thyroid hormone receptor beta1. Endocrinology, 156, 3853–3865. https://doi.org/10.1210/en.2015-1468.
Ng, L., et al. (2004). Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proceedings of the National Academy of Sciences of the United States of America, 101, 3474–3479. https://doi.org/10.1073/pnas.0307402101.
Ng, L., et al. (2009). A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology, 150, 1952–1960. https://doi.org/10.1210/en.2008-1419.
Ng, L., et al. (2001). A thyroid hormone receptor that is required for the development of green cone photoreceptors. Nature Genetics, 27, 94–98. https://doi.org/10.1038/83829.
Nikrodhanond, A. A., et al. (2006). Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. The Journal of Biological Chemistry, 281, 5000–5007.
Onate, S. A., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science (New York, NY), 270, 1354–1357.
Paradies, G., & Ruggiero, F. M. (1990). Enhanced activity of the tricarboxylate carrier and modification of lipids in hepatic mitochondria from hyperthyroid rats. Archives of Biochemistry and Biophysics, 278, 425–430.
Paradies, G., Ruggiero, F. M., Petrosillo, G., & Quagliariello, E. (1996). Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats. FEBS Letters, 397, 260–262.
Paradies, G., Ruggiero, F. M., Petrosillo, G., & Quagliariello, E. (1997). Alterations in carnitine-acylcarnitine translocase activity and in phospholipid composition in heart mitochondria from hypothyroid rats. Biochimica et Biophysica Acta, 1362, 193–200.
Park, E. A., Song, S., Vinson, C., & Roesler, W. J. (1999). Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription. The Journal of Biological Chemistry, 274, 211–217.
Perello, M., Friedman, T., Paez-Espinosa, V., Shen, X., Stuart, R. C., & Nillni, E. A. (2006). Thyroid hormones selectively regulate the posttranslational processing of prothyrotropin-releasing hormone in the paraventricular nucleus of the hypothalamus. Endocrinology, 147, 2705–2716.
Perello, M., & Nillni, E. A. (2007). The biosynthesis and processing of neuropeptides: Lessons from prothyrotropin releasing hormone (proTRH). Frontiers in Bioscience, 12, 3554–3565.
Perissi, V., et al. (1999). Molecular determinants of nuclear receptor-corepressor interaction. Genes & Development, 13, 3198–3208.
Perra, A., et al. (2008). Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. The FASEB Journal, 22, 2981–2989. https://doi.org/10.1096/fj.08-108464.
Piehl, S., Hoefig, C. S., Scanlan, T. S., & Kohrle, J. (2011). Thyronamines--past, present, and future. Endocrine Reviews, 32, 64–80. https://doi.org/10.1210/er.2009-0040.
Psarra, A. M., Solakidi, S., & Sekeris, C. E. (2006). The mitochondrion as a primary site of action of steroid and thyroid hormones: Presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells. Molecular and Cellular Endocrinology, 246, 21–33. https://doi.org/10.1016/j.mce.2005.11.025.
Qatanani, M., Zhang, J., & Moore, D. D. (2005). Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology, 146, 995–1002.
Refetoff, S., Weiss, R. E., & Usala, S. J. (1993). The syndromes of resistance to thyroid hormone. Endocrine Reviews, 14, 348–399.
Rodgers, J. T., Lerin, C., Gerhart-Hines, Z., & Puigserver, P. (2008). Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Letters, 582, 46–53. https://doi.org/10.1016/j.febslet.2007.11.034.
Rosenbaum, M., et al. (2005). Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. The Journal of Clinical Investigation, 115, 3579–3586.
Rosenbaum, M., Murphy, E. M., Heymsfield, S. B., Matthews, D. E., & Leibel, R. L. (2002). Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. The Journal of Clinical Endocrinology and Metabolism, 87, 2391–2394.
Santillo, A., Burrone, L., Falvo, S., Senese, R., Lanni, A., & Chieffi Baccari, G. (2013). Triiodothyronine induces lipid oxidation and mitochondrial biogenesis in rat Harderian gland. The Journal of Endocrinology, 219, 69–78. https://doi.org/10.1530/JOE-13-0127.
Schally, A. V., Redding, T. W., Bowers, C. Y., & Barrett, J. F. (1969). Isolation and properties of porcine thyrotropin-releasing hormone. The Journal of Biological Chemistry, 244, 4077–4088.
Schaner, P., Todd, R. B., Seidah, N. G., & Nillni, E. A. (1997). Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. The Journal of Biological Chemistry, 272, 19958–19968.
Segerson, T. P., Kauer, J., Wolfe, H. C., Mobtaker, H., Wu, P., Jackson, I. M., & Lechan, R. M. (1987). Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science (New York, NY), 238, 78–80.
Shin, D. J., & Osborne, T. F. (2003). Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding Protein-2 (SREBP-2). The Journal of Biological Chemistry, 278, 34114–34118. https://doi.org/10.1074/jbc.M305417200.
Shupnik, M. A., Weck, J., & Hinkle, P. M. (1996). Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C. Molecular Endocrinology (Baltimore, MD), 10, 90–99. https://doi.org/10.1210/mend.10.1.8838148.
Siegrist-Kaiser, C. A., Juge-Aubry, C., Tranter, M. P., Ekenbarger, D. M., & Leonard, J. L. (1990). Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. A novel, extranuclear action of thyroid hormone. The Journal of Biological Chemistry, 265, 5296–5302.
Silva, J. E. (2006). Thermogenic mechanisms and their hormonal regulation. Physiological Reviews, 86, 435–464.
Spencer, C. A., Lum, S. M., Wilber, J. F., Kaptein, E. M., & Nicoloff, J. T. (1983). Dynamics of serum thyrotropin and thyroid hormone changes in fasting. The Journal of Clinical Endocrinology and Metabolism, 56, 883–888.
St Germain, D. L., Galton, V. A., & Hernandez, A. (2009). Minireview: Defining the roles of the iodothyronine deiodinases: Current concepts and challenges. Endocrinology, 150, 1097–1107. https://doi.org/10.1210/en.2008-1588.
Sugrue, M. L., Vella, K. R., Morales, C., Lopez, M. E., & Hollenberg, A. N. (2010). The thyrotropin-releasing hormone gene is regulated by thyroid hormone at the level of transcription in vivo. Endocrinology, 151, 793–801.
Taylor, T., Gesundheit, N., & Weintraub, B. D. (1986). Effects of in vivo bolus versus continuous TRH administration on TSH secretion, biosynthesis, and glycosylation in normal and hypothyroid rats. Molecular and Cellular Endocrinology, 46, 253–261.
Thijssen-Timmer, D. C., Schiphorst, M. P., Kwakkel, J., Emter, R., Kralli, A., Wiersinga, W. M., & Bakker, O. (2006). PGC-1alpha regulates the isoform mRNA ratio of the alternatively spliced thyroid hormone receptor alpha transcript. Journal of Molecular Endocrinology, 37, 251–257. https://doi.org/10.1677/jme.1.01914.
Thompson, G. R., Soutar, A. K., Spengel, F. A., Jadhav, A., Gavigan, S. J., & Myant, N. B. (1981). Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proceedings of the National Academy of Sciences of the United States of America, 78, 2591–2595.
Trost, S. U., et al. (2000). The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity. Endocrinology, 141, 3057–3064. https://doi.org/10.1210/endo.141.9.7681.
Vaitkus, J. A., Farrar, J. S., & Celi, F. S. (2015). Thyroid hormone mediated modulation of energy expenditure. International Journal of Molecular Sciences, 16, 16158–16175. https://doi.org/10.3390/ijms160716158.
van Marken Lichtenbelt, W. D., et al. (2009). Cold-activated brown adipose tissue in healthy men. The New England Journal of Medicine, 360, 1500–1508. https://doi.org/10.1056/NEJMoa0808718.
Vansell, N. R., & Klaassen, C. D. (2001). Increased biliary excretion of thyroxine by microsomal enzyme inducers. Toxicology and Applied Pharmacology, 176, 187–194.
Vansell, N. R., & Klaassen, C. D. (2002). Increase in rat liver UDP-glucuronosyltransferase mRNA by microsomal enzyme inducers that enhance thyroid hormone glucuronidation. Drug Metabolism and Disposition, 30, 240–246.
Vella, K. R., & Hollenberg, A. N. (2009). The ups and downs of thyrotropin-releasing hormone. Endocrinology, 150, 2021–2023.
Vella, K. R., et al. (2014). Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. Molecular and Cellular Biology, 34, 1564–1575. https://doi.org/10.1128/MCB.00129-14.
Vella, K. R. et al. (2011) NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways Cell Metabolism 14:780-790 doi:S1550–4131(11)00403–7 [pii] https://doi.org/10.1016/j.cmet.2011.126009.
Villicev, C. M., et al. (2007). Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. The Journal of Endocrinology, 193, 21–29. https://doi.org/10.1677/joe.1.07066.
Visser, T. J. (1996). Pathways of thyroid hormone metabolism. Acta Medica Austriaca, 23, 10–16.
Weiss, R. E., Gehin, M., Xu, J., Sadow, P. M., O'Malley, B. W., Chambon, P., & Refetoff, S. (2002). Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: Evidence for haploinsufficiency. Endocrinology, 143, 1554–1557.
Weiss, R. E., Xu, J., Ning, G., Pohlenz, J., O'Malley, B. W., & Refetoff, S. (1999). Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. The EMBO Journal, 18, 1900–1904.
Wrutniak, C., et al. (1995). A 43-kDa protein related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver. The Journal of Biological Chemistry, 270, 16347–16354.
Wulf, A., Harneit, A., Kroger, M., Kebenko, M., Wetzel, M. G., & Weitzel, J. M. (2008). T3-mediated expression of PGC-1alpha via a far upstream located thyroid hormone response element. Molecular and Cellular Endocrinology, 287, 90–95. https://doi.org/10.1016/j.mce.2008.01.017.
Yamada, M., et al. (1995). Activation of the thyrotropin-releasing hormone (TRH) receptor by a direct precursor of TRH, TRH-Gly. Neuroscience Letters, 196, 109–112.
Yamada, M., et al. (1997). Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proceedings of the National Academy of Sciences of the United States of America, 94, 10862–10867.
Yang, Z., & Privalsky, M. L. (2001). Isoform-specific transcriptional regulation by thyroid hormone receptors: Hormone-independent activation operates through a steroid receptor mode of co-activator interaction. Molecular Endocrinology (Baltimore, MD), 15, 1170–1185. https://doi.org/10.1210/mend.15.7.0656.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Vella, K.R. (2018). The Thyroid Hormone Axis: Its Roles in Body Weight Regulation, Obesity, and Weight Loss. In: Nillni, E. (eds) Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function. Springer, Cham. https://doi.org/10.1007/978-3-319-89506-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-89506-2_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89505-5
Online ISBN: 978-3-319-89506-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)